Vince Anzalone | Vice President, Investor Relations |
Chris Anzalone | President & Chief Executive Officer |
Javier San Martin | Chief Medical Officer |
James Hamilton | Chief Discovery & Translational Medicine |
Ken Myszkowski | Chief Financial Officer |
Luca Issi | RBC Capital |
Maury Raycroft | Jefferies |
Patrick Trucchio | HC Wainwright & Company |
Keay Nakae | Chardan |
Edward Tenthoff | Piper Sandler |
Mani Foroohar | Leerink Partners |
Mike Ulz | Morgan Stanley |
Mayank Mamtani | B. Riley Securities |
Ellie Merle | UBS |
William Pickering | Bernstein |
Brendan Smith | TD Cowen |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only. After the presentation, there will be an opportunity to ask questions.
I will now hand the conference over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.